Evidence map›Paper›PMID 35480825›Full record

ArticleRSC advances2021

Ahmed E Allam, Yhiya Amen, Ahmed Ashour, Hamdy K Assaf, Heba Ali Hassan, Islam M Abdel-Rahman, Ahmed M Sayed, Kuniyoshi Shimizu

Abstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Pro-Apoptotic Activity ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Exploring the volatile metabolites of threeSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. RSC advances · 2022
    Article
  15. Article
  16. Plants (Basel, Switzerland) · 2022
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ahmed E AllamDepartment of Pharmacognosy, Faculty of Pharmacy, Al-Azhar University Assiut 71524 Egypt aallam81@yahoo.co.uk.ORCID https://orcid.org/0000-0003-0286-581X
Yhiya AmenDepartment of Pharmacognosy, Faculty of Pharmacy, Mansoura University Mansoura 35516 Egypt.
Ahmed AshourDepartment of Pharmacognosy, Faculty of Pharmacy, Mansoura University Mansoura 35516 Egypt.ORCID https://orcid.org/0000-0003-4081-0369
Hamdy K AssafDepartment of Pharmacognosy, Faculty of Pharmacy, Al-Azhar University Assiut 71524 Egypt aallam81@yahoo.co.uk.
Heba Ali HassanDepartment of Pharmacognosy, Faculty of Pharmacy, Deraya University, Universities Zone New Minia City 61111 Egypt.ORCID https://orcid.org/0000-0002-2631-5831
Islam M Abdel-RahmanDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University New-Minia 61111 Egypt.
Ahmed M SayedDepartment of Pharmacognosy, Faculty of Pharmacy, Nahda University Beni-Suef 62513 Egypt.ORCID https://orcid.org/0000-0002-1442-183X
Kuniyoshi ShimizuDepartment of Agro-Environmental Sciences, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University Fukuoka Japan 819-0395.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products and traditional medicine products with known safety profiles are a promising source for the discovery of new drug leads. Natural products as sesame were reported to exhibit potential to protect from COVID-19 disease. In our study, the total methanolic extract of

Identifiers

PMID35480825
PMCPMC9034212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.